SET Nuclear Oncogene (SET) (N-Term) Peptide
SET
Host: Synthetic
BP, IHC, WB, IP
Catalog No. ABIN8111551
$145.08
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 2 to 4 Business Days
Quick Overview for SET Nuclear Oncogene (SET) (N-Term) Peptide (ABIN8111551)
Target
SET/TAF-I (SET)
(SET Nuclear Oncogene (SET))
Source
Synthetic
Application
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP)
-
-
Protein Region
- N-Term
-
Purpose
- SET Peptide - N-terminal region
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Comment
-
This is a synthetic peptide designed for use in combination with anti-SET antibody ( ARP56542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Background
-
Background Information: SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-indu
Alternative Symbols: 2PP2A, I2PP2A, IGAAD, PHAPII, TAF-IBETA, TAF-I, IPP2A2
-
Molecular Weight
- 32kDa
-
Gene ID
- 6418
-
NCBI Accession
- NP_003002
-
UniProt
- B2RCX0
Target
-
You are here:
